510(k) Report

510(k) · Cleared

Cleared

RemunityPRO™ Pump for Remodulin® (treprostinil) Injection

K250357510(k) SpecialCleared Mar 11, 202532-day reviewClass II21 CFR 880.5725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Deka Research & Development Corp. · FRN Pump, Infusion

Cleared on Mar 11, 2025 as substantially equivalent to K241736 (Deka Research and Development Corp., 2025) after a 32-day review. Its family tree reaches back 3 generations to 2005. 1 later device descends from it.

Decided
Mar 11, 2025
Review
32 days
Class
Class II
Product code
FRN
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K051568 (2005). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK051568 Cadd-MS 3 Ambulatory Infusion PumpSmiths Medical MD, Inc. · 2005 · Recalled
  2. 2 generations backK190182 Unity Subcutaneous Delivery System for RemodulinDEKA Research & Development · 2019
  3. 1 generation backK241736 Remunity 2.0 Pump for Remodulin (treprostinil) InjectionDeka Research and Development Corp. · 2025
  4. This deviceK250357 RemunityPRO™ Pump for Remodulin® (treprostinil) InjectionDeka Research & Development Corp. · 2025
  5. Descendant · cites it directly · 0 of its ownK253703 RemunityPRO+ Pump for Remodulin® (treprostinil) InjectionDeka R&D Corp · 2026

Most influential descendants

Showing 1 of 1 · See all
  • K253703RemunityPRO+ Pump for Remodulin® (treprostinil) InjectionDeka R&D Corp · 2026 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K051568Cadd-MS 3 Ambulatory Infusion PumpSmiths Medical MD, Inc.20052
−2K190182Unity Subcutaneous Delivery System for RemodulinDEKA Research & Development2019—
−1K241736Remunity 2.0 Pump for Remodulin (treprostinil) InjectionDeka Research and Development Corp.2025—
0 (this device)K250357RemunityPRO™ Pump for Remodulin® (treprostinil) InjectionDeka Research & Development Corp.2025—
+1K253703RemunityPRO+ Pump for Remodulin® (treprostinil) InjectionDeka R&D Corp2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202610
FIG. 1 — Lineage of K250357, 2005–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FRN device

  1. #1 K253703 RemunityPRO+ Pump for Remodulin®…score 12.6 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K241736Remunity 2.0 Pump for Remodulin (treprostinil) Injection
Summary page 5
…II Device Panel: General Hospital Predicate Device The predicate device is the Remunity® 2.0 Pump for Remodulin® (treprostinil) Injection, K241736, cleared on January 16, 2025. The predicate device has not been subject to a design-related recall. Device Description The Remu…
Deka Research and Development Corp.2025—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K253703RemunityPRO+ Pump for Remodulin® (treprostinil) InjectionDeka R&D Corp20260

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 4 companies; a new generation was cleared every 5.7 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K253703 (Deka R&D Corp, 2026) has gone furthest, with 0 descendants of its own.

How does its category compare?

All FRN devices

FRN Pump, Infusion: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · FRN

8in 2025

2007: 122008: 82009: 92010: 32011: 32012: 42013: 62014: 62015: 32016: 32017: 32018: 32019: 22020: 12021: 22022: 62023: 72024: 52025: 82026 (partial year): 2
2007high 12 (2007) · low 1 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FRN

172in 2025

2007: 102 days median2008: 89 days median2009: 66 days median2010: 93 days median2011: 103 days median2012: 217 days median2013: 312 days median2014: 172 days median2015: 232 days median2016: 301 days median2017: 305 days median2018: 267 days median2022: 268 days median2023: 265 days median2024: 103 days median2025: 172 days median
2007high 312 (2013) · low 66 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FRN

7in 2025

2007: 152008: 242009: 1022010: 372011: 692012: 42, 2 Class I2013: 22, 3 Class I2014: 4, 3 Class I2015: 52016: 7, 1 Class I2017: 132018: 12019: 18, 1 Class I2020: 16, 5 Class I2021: 3, 2 Class I2022: 22023: 16, 10 Class I2024: 9, 4 Class I2025: 7, 4 Class I2026 (partial year): 11, 2 Class I
2007high 102 (2009) · low 1 (2018)2026

Class I (37 since 2007) Class II/III not classified

Adverse event reports per year · FRN

52,792in 2025

2007: 1,0862008: 8,2612009: 1,9522010: 6,1332011: 41,3672012: 15,4822013: 40,0822014: 94,1802015: 26,7422016: 16,5602017: 12,0602018: 16,5912019: 15,8502020: 94,1862021: 199,3422022: 888,0202023: 165,8382024: 57,7302025: 52,792
2007high 888,020 (2022) · low 1,086 (2007)2025

MAUDE reports naming product code FRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200712102151,086
2008889248,261
20099661021,952
2010393376,133
201131036941,367
2012421742 (2)15,482
2013631222 (3)40,082
201461724 (3)94,180
20153232526,742
201633017 (1)16,560
201733051312,060
20183267116,591
20192—18 (1)15,850
20201—16 (5)94,186
20212—3 (2)199,342
202262682888,020
2023726516 (10)165,838
202451039 (4)57,730
202581727 (4)52,792
20262—11 (2)—

What is it indicated for?

The RemunityPRO™ Pump for Remodulin® (treprostinil) Injection (the RemunityPRO System) is intended for

continuous subcutaneous delivery of Remodulin (treprostinil) Injection for use in patients, ages 17 and older.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K250357: RemunityPRO™ Pump for Remodulin® (treprostinil) Injection.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K250357

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026